Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis.
Although radiation therapy is a major risk factor for the development of lymphedema following lymphadenectomy, the mechanisms responsible for this effect remain unknown. The purpose of this study was therefore to determine the effects of radiation on lymphatic endothelial cells (LECs) and lymphatic function. The tails of wild-type or acid sphingomyelinase (ASM)-deficient mice were treated with 0, 15, or 30 Gy of radiation and then analyzed for LEC apoptosis and lymphatic function at various time points. To analyze the effects of radiation fibrosis on lymphatic function, we determined the effects of transforming growth factor (TGF)-beta1 blockade after radiation in vivo. Finally, we determined the effects of radiation and exogenous TGF-beta1 on LECs in vitro. Radiation caused mild edema that resolved after 12-24 wk. Interestingly, despite resolution of tail edema, irradiated animals displayed persistent lymphatic dysfunction. Radiation caused loss of capillary lymphatics and was associated with a dose-dependent increase in LEC apoptosis. ASM-/- mice had significantly less LEC apoptosis; however, this finding did not translate to improved lymphatic function at later time points. Short-term blockade of TGF-beta1 function after radiation markedly decreased tissue fibrosis and significantly improved lymphatic function but did not alter LEC apoptosis. Radiation therapy decreases lymphatic reserve by causing depletion of lymphatic vessels and LECs as well as promoting soft tissue fibrosis. Short-term inhibition of TGF-beta1 activity following radiation improves lymphatic function and is associated with decreased soft tissue fibrosis. ASM deficiency confers LEC protection from radiation-induced apoptosis but does not prevent lymphatic dysfunction.
Avraham
Tomer
T
Division of Plastic and Reconstructive Surgery, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Yan
Alan
A
Zampell
Jamie C
JC
Daluvoy
Sanjay V
SV
Haimovitz-Friedman
Adriana
A
Cordeiro
Andrew P
AP
Mehrara
Babak J
BJ
D000818:Animals; D017209:Apoptosis / Q000528:radiation effects; D002460:Cell Line; D016922:Cellular Senescence / Q000528:radiation effects; D003094:Collagen / Q000096:biosynthesis; D042783:Endothelial Cells / Q000473:pathology / Q000502:physiology / Q000528:radiation effects; D005355:Fibrosis; D006801:Humans; D042601:Lymphatic Vessels / Q000473:pathology / Q000503:physiopathology / Q000528:radiation effects*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D011833:Radiation Injuries, Experimental / Q000209:etiology / Q000473:pathology* / Q000503:physiopathology*; D011878:Radiotherapy / Q000009:adverse effects; D011994:Recombinant Proteins / Q000494:pharmacology; D012867:Skin / Q000187:drug effects / Q000473:pathology / Q000528:radiation effects*; D013108:Sphingomyelin Phosphodiesterase / Q000235:genetics; D053773:Transforming Growth Factor beta1 / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology*; D033921:Vesicular Transport Proteins / Q000096:biosynthesis
C119248:LYVE1 protein, human; D011994:Recombinant Proteins; D053773:Transforming Growth Factor beta1; D033921:Vesicular Transport Proteins; D003094:Collagen; D013108:Sphingomyelin Phosphodiesterase